These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21830834)
21. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621 [TBL] [Abstract][Full Text] [Related]
22. A pyrophosphate-responsive gadolinium(III) MRI contrast agent. Surman AJ; Bonnet CS; Lowe MP; Kenny GD; Bell JD; Tóth E; Vilar R Chemistry; 2011 Jan; 17(1):223-30. PubMed ID: 21207619 [TBL] [Abstract][Full Text] [Related]
23. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Caravan P Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145 [TBL] [Abstract][Full Text] [Related]
24. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands. Pierre VC; Melchior M; Doble DM; Raymond KN Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201 [TBL] [Abstract][Full Text] [Related]
25. Gadolinium(III) complexes of 1,4,7-triazacyclononane based picolinate ligands: simultaneous optimization of water exchange kinetics and electronic relaxation. Nonat A; Giraud M; Gateau C; Fries PH; Helm L; Mazzanti M Dalton Trans; 2009 Oct; (38):8033-46. PubMed ID: 19771367 [TBL] [Abstract][Full Text] [Related]
26. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents. Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814 [TBL] [Abstract][Full Text] [Related]
27. Lanthanide complexes of a picolinate ligand derived from 1,4,7-triazacyclononane with potential application in magnetic resonance imaging and time-resolved luminescence imaging. Nonat A; Gateau C; Fries PH; Mazzanti M Chemistry; 2006 Sep; 12(27):7133-50. PubMed ID: 16755632 [TBL] [Abstract][Full Text] [Related]
29. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm. Woods M; Kiefer GE; Bott S; Castillo-Muzquiz A; Eshelbrenner C; Michaudet L; McMillan K; Mudigunda SD; Ogrin D; Tircsó G; Zhang S; Zhao P; Sherry AD J Am Chem Soc; 2004 Aug; 126(30):9248-56. PubMed ID: 15281814 [TBL] [Abstract][Full Text] [Related]
31. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Werner EJ; Datta A; Jocher CJ; Raymond KN Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758 [TBL] [Abstract][Full Text] [Related]
32. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
33. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Xu J; Churchill DG; Botta M; Raymond KN Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797 [TBL] [Abstract][Full Text] [Related]
34. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936 [TBL] [Abstract][Full Text] [Related]
35. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
36. Triethylenetetramine penta- and hexa-acetamide ligands and their ytterbium complexes as paraCEST contrast agents for MRI. Burdinski D; Lub J; Pikkemaat JA; Moreno Jalón D; Martial S; Del Pozo Ochoa C Dalton Trans; 2008 Aug; (31):4138-51. PubMed ID: 18688432 [TBL] [Abstract][Full Text] [Related]
37. Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe. Vologdin N; Rolla GA; Botta M; Tei L Org Biomol Chem; 2013 Feb; 11(10):1683-90. PubMed ID: 23360969 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging. Nithyakumar A; Alexander V Dalton Trans; 2015 Oct; 44(40):17800-9. PubMed ID: 26400754 [TBL] [Abstract][Full Text] [Related]
39. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. Thompson MK; Botta M; Nicolle G; Helm L; Aime S; Merbach AE; Raymond KN J Am Chem Soc; 2003 Nov; 125(47):14274-5. PubMed ID: 14624565 [TBL] [Abstract][Full Text] [Related]
40. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]